A recent study by University of California at Los Angeles (UCLA) researchers touts the many health benefits of curcumin, which has shown to improve memory and mood with its anti-inflammatory and antioxidant properties.
University of California, Los Angeles (UCLA) researchers reported they have found an engineered flu virus that induced strong immune responses in animals and could pave the way for a new type of "at home" nasal spray vaccine to combat the flu.
A recent study by University of California, Los Angeles (UCLA), researchers has provided important information on how the herpes virus, associated with a type of cancer, spreads and could aid in the development of antiviral drugs.
Research from the University of Colorado's Anschutz Medical Campus has shown that an antioxidant found in certain foods can stop the progression of fatty liver disease, which has become a major public health issue in the United States.
A new study by researchers at the University of Florida (UF) College of Public Health and Health Professions shows those who had significant weight loss start regaining their weight much sooner than originally believed.
Researchers with the National Heart Lung and Blood Institute (NHLBI) recently found genetic variations which may be indicators of those who are at risk for chronic obstructive pulmonary disease (COPD).
A recent study by National Institutes of Health (NIH) researchers indicates that a short-term pause in HIV treatment, known as analytical treatment interruption (ATI), does not effect the HIV reservoir or damage the patient's immune system.
Researchers with the National Institutes of Health (NIH) have completed a study that indicates women with moderate iodine deficiency may have a reduced chance of becoming pregnant compared to women with normal iodine levels.
In an effort to support the estimated 30 million Americans facing rare diseases, the National Organization for Rare Disorders (NORD) recently launched a new awareness effort challenging people to pledge dollars for walking, running or biking 7,000 miles throughout the month of February.
Merck said Lynparza (olaparib), a targeted therapy co-developed with AstraZeneca, has become the first PARP inhibitor approved by the Food and Drug Administration for treating metastatic breast cancer.
Johnson & Johnson said it is seeking nominations for its Dr. Paul Janssen Award for Biomedical Research, which includes a $200,000 cash prize to researchers and scientists whose work has made significant contributions to improving human health.
The Centers for Medicare & Medicaid (CMS) recently approved its first 10-year extension demonstration under Medicaid for Mississippi, a move that will expand coverage for family-planning services in the state.
Vanderbilt University's Board of Trust recently approved a degree program for genetic counseling, one of the fastest growing health professions in the United States, as enrollment begins for its inaugural semester in fall 2019.